AzTrials
AzTrials

FatigueNCT07188831

Effect of Agarwood (Aquilaria Sinensis) Inhalation Aromatherapy on Workplace Fatigue and Sleep Quality Among Hospital Employees: A Randomized Controlled Trial

A study testing Agarwood Aromatherapy Inhalation in people with Fatigue and Occupational Stress or Workplace Stress, run by Da-Yeh University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Hospital staff often experience workplace fatigue and poor sleep quality, which can harm their health, reduce job performance, and increase risks to patient safety. Aromatherapy is a simple, non-invasive complementary therapy that may help reduce fatigue and improve sleep. Read more about this study

Who is it for?
Ages 20 years and older
What is being tested?
Agarwood Aromatherapy Inhalation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
78 participants
Where
No sites listed yet
Study dates
Sep 2025to Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ≥20 years old, hospital employee working ≥30 hrs/week, employed ≥3 months
  • Not using sedatives/hypnotics
  • Normal olfactory function (verified with coffee/vinegar smell test)
  • Clear consciousness, can read and understand Chinese, no major communication barriers
  • Not participating in other aromatherapy or relaxation intervention studies

Who cannot join

  • Major psychiatric disorders (e.g., major depression, schizophrenia)
  • Malignancy under active radio/chemotherapy
  • CNS diseases (e.g., brain tumor)
  • History of asthma, fragrance allergy, pregnancy
  • Chronic rhinitis, nasal surgery, anosmia
  • Permanent night-shift workers (≥ midnight to 5am, as defined by ILO, 1995)

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: A Randomized Controlled Trial Examining the Impact of Agarwood Aromatherapy Inhalation on Sleep Quality and Occupational Fatigue in Hospital Staff

Hospital staff often experience workplace fatigue and poor sleep quality, which can harm their health, reduce job performance, and increase risks to patient safety. Aromatherapy is a simple, non-invasive complementary therapy that may help reduce fatigue and improve sleep. Agarwood (Aquilaria spp.) has calming and relaxing properties, but there is little clinical research on its effectiveness for hospital staff.

This randomized, double-blind, controlled trial will evaluate whether agarwood aromatherapy inhalation can improve fatigue and sleep quality among hospital employees in Taiwan. About 78 participants will be recruited and randomly assigned to one of two groups:

Read more
  1. Experimental group: Agarwood sachet containing agarwood wood chips and essential oil.
  2. Control group: Placebo sachet containing almond oil.

Participants will place the sachet about 60 cm from the nose during sleep for 7 nights. Data will be collected using questionnaires on workplace fatigue and sleep quality (Pittsburgh Sleep Quality Index, PSQI). The main questions this study aims to answer are: 1. Does agarwood aromatherapy reduce workplace fatigue in hospital staff? 2. Does agarwood aromatherapy improve sleep quality compared with placebo?

Findings are expected to provide scientific evidence for using agarwood inhalation as a safe and convenient strategy to improve staff well-being and support a healthier hospital environment.

Being tested
Agarwood Aromatherapy Inhalation
Medical subject headings
Fatigue, Occupational Stress, Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Agarwood Aromatherapy InhalationOther

    The experimental group will receive agarwood essential oil sachets as the aromatherapy intervention, and participants will place the sachet 60 cm from the nose during sleep for one week.

Study groups in NCT07188831
Study groupRoleWhat they receive
Group of agarwoodExperimentalInhalation of agarwood (Aquilaria crassna, "Guangdong green kyara") wood chips + 2 drops agarwood essential oil in sachet, and exposure during sleep for 7-8 hrs/night × 7 nights
Receives: Other: Agarwood Aromatherapy Inhalation
Group of sachetActive comparatorInhalation of sachet containing diffuser sticks soaked with sweet almond carrier oil (odorless placebo), and same exposure schedule
Receives: Other: Agarwood Aromatherapy Inhalation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Workplace Fatigue

    Change in fatigue levels measured by the Chinese version of the Copenhagen Burnout Inventory (21 items across four domains: personal, work-related, client-related, and overcommitment). Higher scores indicate greater fatigue.

    Measured: Baseline and after 1-week intervention

Secondary outcomes (1)
  1. Sleep Quality

    Change in sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI, 19 items, 7 domains). Total scores range from 0 to 21, with higher scores indicating poorer sleep quality.

    Measured: Baseline and after 1-week intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Sep 2025
  2. Study startSep 2025 (estimated)
  3. Primary completionJul 2026 (estimated)
  4. Study completionJul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
78 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07188831
Sponsor's protocol ID
DYU-AGARWOOD-2025
Status last verified
Sep 2025
First submitted
16 Sep 2025
Last updated
23 Sep 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared because of privacy concerns and institutional data protection policies.

Questions about this trial

What is this clinical trial studying?

A study testing Agarwood Aromatherapy Inhalation in people with Fatigue and Occupational Stress or Workplace Stress, run by Da-Yeh University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yi-chen Wu, PhD (+886-4-8511888 ext. 7215, yichenwu@mail.dyu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Workplace Fatigue (time frame: Baseline and after 1-week intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in